TEVA PHARMACEUTICAL-SP ADR (TEVA) Institutional Ownership and Insiders Activity

TEVA PHARMACEUTICAL-SP ADR (TEVA) is widely held by institutional investors, with 658 firms reporting positions valued at approximately $24.44B based on SEC Form 13F filings for the quarter ended June 30, 2026.

Blackrock, Inc. is the largest disclosed holder, reporting approximately $2.16B in TEVA holdings in its latest filing.

Recent insider activity includes 8 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.

Institutional Holders

658

Total Reported Value

$24.44B

Largest Holder

Blackrock, Inc.

Largest Position

$2.16B

Insider Transactions (90d)

8

Latest Filing Quarter

Q2 2026

New Institutional Positions

88

Funds Exiting Positions

78